It is a useful indicator to differentiate between high and low-grade gliomas, in which low Ki-67 expression levels are directly associated with grade II–III whilst high Ki-67 expression levels are directly associated with high grade IV gliomas [21]. This evidence concerns the gene MKI67 and central nervous system cancer.